Landau-Kleffner syndrome and CSWS syndrome: Treatment with intravenous immunoglobulins

被引:46
作者
Arts, Willem F. M. [1 ]
Aarsen, Femke K. [1 ]
Scheltens-de Boer, Marjan [2 ]
Catsman-Berrevoets, Coriene E. [1 ]
机构
[1] Erasmus MC, Dept Paediat Neurol, NL-3000 CB Rotterdam, Netherlands
[2] Erasmus MC, Dept Clin Neurophysiol, NL-3000 CB Rotterdam, Netherlands
关键词
Aphasia; Epilepsy; Children; Treatment; GAMMA-GLOBULIN; EPILEPSY; CHILDHOOD; CHILDREN; THERAPY; SLEEP;
D O I
10.1111/j.1528-1167.2009.02221.x
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
This study reports results of therapy with immunoglobulin in children with Landau-Kleffner syndrome (LKS) or the syndrome of continuous spikes and waves during sleep (CSWS syndrome). In a prospective study, children diagnosed between 2002 and 2006 with either LKS or CSWS syndrome were treated soon after diagnosis with intravenous courses of immunoglobulin (IVIg). We compared the results with those reported in the literature and with data from a retrospective survey of our earlier patients. Six children (two girls), aged 4-9 years, were included. Three had LKS, and three had CSWS syndrome. One child-with typical LKS-had been treated with prednisone before (without response). No patient had seizures during IVIg treatment and follow-up. Their electroencephalography (EEG) findings did not improve. Neuropsychological improvement occurred in one child with CSWS syndrome. Three children did not show any beneficial effect; they were subsequently treated with steroids, one with a clearly positive result. We conclude that successful treatment of LKS and CSWS syndrome with IVIg occurs occasionally. However, the improvement cannot always be clearly attributed to this. It might also reflect the natural course of the disease. Although the temporal relation between IVIg treatment and clinical improvement cannot be denied in individual patients, its real value remains to be determined.
引用
收藏
页码:55 / 58
页数:4
相关论文
共 16 条
  • [1] Intravenous immunoglobulins in refractory childhood-onset epilepsy: Effects on seizure frequency, EEG activity, and cerebrospinal fluid cytokine profile
    Billiau, An D.
    Witters, Peter
    Ceulemans, Berten
    Kasran, Ahmad
    Wouters, Carine
    Lagae, Lieven
    [J]. EPILEPSIA, 2007, 48 (09) : 1739 - 1749
  • [2] Epilepsy and the immune system: is there a link?
    Billiua, AD
    Wouters, CH
    Lagae, LG
    [J]. EUROPEAN JOURNAL OF PAEDIATRIC NEUROLOGY, 2005, 9 (01) : 29 - 42
  • [3] Immunoglobulins in children with epilepsy: The Dutch Study of Epilepsy in Childhood
    Callenbach, PMC
    Jol-Van der Zijde, CM
    Geerts, AT
    Arts, WFM
    Van Donselaar, CA
    Peters, ACB
    Stroink, H
    Brouwer, OF
    van Tol, MJD
    [J]. CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2003, 132 (01) : 144 - 151
  • [4] Landau-Kleffner syndrome: Consistent response to repeated intravenous gamma-globulin doses: A case report
    Fayad, MN
    Choueiri, R
    Mikati, M
    [J]. EPILEPSIA, 1997, 38 (04) : 489 - 494
  • [5] Successful use of intravenous immunoglobulins in Landau-Kleffner syndrome
    Lagae, LG
    Silberstein, J
    Gillis, PL
    Casaer, PJ
    [J]. PEDIATRIC NEUROLOGY, 1998, 18 (02) : 165 - 168
  • [6] LANDAU-KLEFFNER SYNDROME - A PHARMACOLOGICAL STUDY OF 5 CASES
    MARESCAUX, C
    HIRSCH, E
    FINCK, S
    MAQUET, P
    SCHLUMBERGER, E
    SELLAL, F
    METZLUTZ, MN
    ALEMBIK, Y
    SALMON, E
    FRANCK, G
    KURTZ, D
    [J]. EPILEPSIA, 1990, 31 (06) : 768 - 777
  • [7] MATSUOKA H, 1983, CLIN EXP IMMUNOL, V53, P423
  • [8] Successful use of intravenous immunoglobulin as initial monotherapy in Landau-Kleffner syndrome
    Mikati, MA
    Saab, R
    [J]. EPILEPSIA, 2000, 41 (07) : 880 - 886
  • [9] Efficacy of intravenous immunoglobulin in Landau-Kleffner syndrome
    Mikati, MA
    Saab, R
    Fayad, MN
    Choueiri, RN
    [J]. PEDIATRIC NEUROLOGY, 2002, 26 (04) : 298 - 300
  • [10] Management of Landau-Kleffner syndrome
    Mikati M.A.
    Shamseddine A.N.
    [J]. Pediatric Drugs, 2005, 7 (6) : 377 - 389